Core B (Animal Component)
核心B(动物成分)
基本信息
- 批准号:10421280
- 负责人:
- 金额:$ 23.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adipose tissueAnimal ExperimentsAnimal HusbandryAnimalsBreedingCRISPR/Cas technologyCaringCellsCollaborationsDNADataDiseaseEmbryoEmbryo TransferEquipmentFOXO1A geneFeeding behaviorsFemaleFertilization in VitroFosteringFunctional disorderFundingGene TargetingGenerationsGenesGenetically Engineered MouseGenotypeGuidelinesHomeostasisHumanHuman ResourcesHypothalamic structureInstitutesKnock-inKnock-outLiverMaintenanceMediatingMediator of activation proteinMessenger RNAMetabolicMetabolic DiseasesMetabolic PathwayMetabolismMethodologyMethodsMolecular TargetMusMutant Strains MiceNuclear ReceptorsOvulationPPAR alphaPPAR gammaPathway interactionsPhysiologicalProductionProgram EffectivenessProgram Research Project GrantsProtein IsoformsProteinsProtocols documentationRegulator GenesResearchResearch PersonnelResourcesRoleSTAT3 geneSavingsServicesSiteSystemTechnologyTherapeuticTimeTrainingTransgenesTransgenic MiceTransgenic OrganismsUnited States National Institutes of HealthVariantXBP1 geneanimal facilityanimal resourcebaseconditional knockoutcost effectivenessembryo cryopreservationembryonic stem cellexperienceexperimental analysisexperimental studygenotypic sexhomologous recombinationknock-downmalemouse genomemouse modelnuclear receptor coactivator 1operationoverexpressionpre-clinicalpreservationprogramssexsperm cryopreservationsuccesstranscription factor
项目摘要
Core B (Animal Component) - Project Summary
All research projects of this Program Project (PP) will rely on the use of genetically engineered mouse (GEM)
models to investigate the roles and mechanism of Nuclear Receptors, transcription factors and their coregulators
in energy and metabolic homeostasis and disease. More specifically, at least 34 GEM mouse lines will be used,
and thousands of male and female mice will be produced by breeding in house during the funding period of this
PP. Therefore, this Animal Component of Core B is essential for the success of this PP by integrating expensive
equipment, advanced technology, experienced personnel and animal resources. As shown by preliminary
studies, Core B has generated/established multiple GEM lines and developed CRISPR-Cas9-mediated mouse
gene editing systems. Core B is dedicated to achieving 3 major objectives. Firstly, Core B will use its specialized
expertise, state-of-the-art equipment and adequate facilities to generate GEM lines for all investigators of this
PP. Core B has established the necessary methods to edit the mouse genome by homologous recombination-
based gene targeting in ES cells or CRISPR/Cas9-based gene editing in 1-cell mouse embryos. Core B will
generate all GEM lines needed by the investigators of this PP. Secondly, Core B will provide high quality mouse
services to manage GEM line colonies and produce genotype-defined and age/sex-matched mice for all
investigators of this PP. Specifically, Core B will breed and maintain all of the 34 mouse lines used by this PP.
Core B will use our colony expansion protocol to produce large numbers of genotype/age/sex-matched mice for
experimental analysis. Core B also will perform genotype analysis, super ovulation, embryo and sperm
cryopreservation, and in vitro fertilization services to help the investigators of this PP for managing their mouse
colonies, preserving GEM lines, transferring mouse lines between institutes, and saving animal husbandry
expenses. Finally, Core B will integrate the efficient usage of animal resources by all investigators of this PP.
Because of the large-scale operation of mouse models and the sharing features of multiple mouse lines among
the projects of this PP, centralized integration of equipment, expertise and valuable mouse resource will be
essential for both scientific success and cost effectiveness. Core B will minimize the expenses of animal
experiments by consolidating the usage and management of equipment, expertise, animal facility, mouse
maintenance and production. In addition, Core B will serve as a resource for execution and technical training in
the use of all animal manipulations needed and oversee the care and use of experimental mice for this PP.
核心B(动物成分)——项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JIANMING XU其他文献
JIANMING XU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JIANMING XU', 18)}}的其他基金
The primary role of low NCOA6 expression in the prostate cancer disparity among African American men
NCOA6 低表达在非裔美国男性前列腺癌差异中的主要作用
- 批准号:
10544740 - 财政年份:2022
- 资助金额:
$ 23.78万 - 项目类别:
The primary role of low NCOA6 expression in the prostate cancer disparity among African American men
NCOA6 低表达在非裔美国男性前列腺癌差异中的主要作用
- 批准号:
10356340 - 财政年份:2022
- 资助金额:
$ 23.78万 - 项目类别:
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer
NCOA6,子宫内膜癌的新型肿瘤抑制因子
- 批准号:
9030156 - 财政年份:2015
- 资助金额:
$ 23.78万 - 项目类别:
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer
NCOA6,子宫内膜癌的新型肿瘤抑制因子
- 批准号:
10057354 - 财政年份:2015
- 资助金额:
$ 23.78万 - 项目类别:
相似海外基金
Development of decellularized small-diameter arterial grafts and evaluation in large animal experiments
脱细胞小直径动脉移植物的研制及大动物实验评价
- 批准号:
21H03016 - 财政年份:2021
- 资助金额:
$ 23.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Developing and validating a computational model of the gut microbiota-mucosa interactions to replace and reduce animal experiments
开发和验证肠道微生物群-粘膜相互作用的计算模型,以取代和减少动物实验
- 批准号:
NC/R001707/1 - 财政年份:2018
- 资助金额:
$ 23.78万 - 项目类别:
Training Grant
Developing and validating a computational model of the gut microbiota-mucosa interactions to replace and reduce animal experiments
开发和验证肠道微生物群-粘膜相互作用的计算模型,以取代和减少动物实验
- 批准号:
2103295 - 财政年份:2018
- 资助金额:
$ 23.78万 - 项目类别:
Studentship
Research on the way of information transmission to gain social understanding of animal experiments
动物实验获得社会理解的信息传递方式研究
- 批准号:
16K07080 - 财政年份:2016
- 资助金额:
$ 23.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CDS&E: Modeling the Zebrafish Model Organism Toward Reducing, Refining, and Replacing Animal Experiments
CDS
- 批准号:
1505832 - 财政年份:2015
- 资助金额:
$ 23.78万 - 项目类别:
Standard Grant
Never replicate a successful experiment? Standardization, heterogenization and reproducibility in animal experiments
从未复制过成功的实验?
- 批准号:
283089959 - 财政年份:2015
- 资助金额:
$ 23.78万 - 项目类别:
Research Grants
Arrhythmogenic Drug Evaluation System by Simplified Animal Experiments
简化动物实验的致心律失常药物评价系统
- 批准号:
26350520 - 财政年份:2014
- 资助金额:
$ 23.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Promotion of the 4Rs in animal experiments by the development of a production process for polyclonal antibodies using a goldfish
开发金鱼多克隆抗体生产工艺,促进动物实验中的4R
- 批准号:
23650227 - 财政年份:2011
- 资助金额:
$ 23.78万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of microangiographic systems to visualize cerebular perforating artery in clinical settings and retrobulbar ophthalmic artery arteries in animal experiments.
开发显微血管造影系统,以在临床环境中可视化小脑穿支动脉,并在动物实验中可视化球后眼动脉。
- 批准号:
23390305 - 财政年份:2011
- 资助金额:
$ 23.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The study for the modification of cerebral synapses by balance exercises in the elderly based on animal experiments.
基于动物实验的老年人平衡运动改变大脑突触的研究。
- 批准号:
21500471 - 财政年份:2009
- 资助金额:
$ 23.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




